Key details
Sponsor
China National Biotec Group Company Limited
Collaborators
Beijing Institute of Biological Products Co Ltd., Shulan (Hangzhou) Hospital
Enrollment target
~76 participants
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 50 Years
Last updated January 2026